MIRA PHARMACEUTICALS, INC. MIRA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2023-08-03
MIRA PHARMACEUTICALS, INC. statistics & valuation
Market cap$42.4M
P / B4.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Return on assets | -94.1% | -268.6% | -242.9% | -822.6% |
| Return on equity | -100.5% | -357.0% | -273.9% | 1183.8% |
| Current ratio | 15.75 | 3.99 | 8.70 | 0.36 |
Source: SEC EDGAR filings · CIK 0001904286 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.